Abstract
This document, produced with the assistance of ChatGPT o3 and GPT-5 Thinking, is released under the Apache 2.0 license. It is a voluntary defensive publication (prior art) and therefore enters the prior art upon release under the applicable patent statutes: EPC Art. 54(2) (European Patent Convention), French IPC/CPI Art. L 611-11 (French Intellectual Property Code), 35 U.S.C. §102(a) (United States Patent Act), Chinese Patent Law Art. 22(5) (中华人民共和国专利法), and Japanese Patent Act Art. 29(1) (特許法). It consolidates 100 enabling embodiments spanning gold nanomedicine (photothermal ablation, CRISPR-Gold delivery, nanozymes, theranostics), whole-body sensing (MRI, OPM/EEG, exposome), imaging/reconstruction (photoacoustics, DECT, PCD-CT), AI (digital twins, safety-constrained bandits/RL, federated/split learning, HE/TEE privacy), closed-loop neuromodulation and perfusion, GMP manufacturing/QA, packaging and traceability. Each item includes reproducible parameters (materials, device specs, acquisition, dosing, QA/PAT) and at least one IPC and one CPC classification, enabling practitioners to implement and thereby pre-empt narrow patents. Timestamp proof (RFC 3161 / FreeTSA) may be attached; cryptographic hash (SHA-256) is provided below. Original Zenodo url: https://zenodo.org/records/17164682
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Recommended Citation
Pillet, Xavier, "Revolutionary Technologies to Extend Lifespan and Personalize Medicine", Technical Disclosure Commons, (September 22, 2025)
https://www.tdcommons.org/dpubs_series/8616